CIM LLC’s West Pharmaceutical WST Stock Holding History

CIM LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,139	Closed	-$809K	–	167
2021 Q4	$809K	Buy	+2,139	New	+$921K	0.15%	89

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

CIM LLC's WST Position: Q1 2022 in Review

CIM LLC sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 2,139 shares — an estimated $809K sold.

CIM LLC first reported a position in WST in Q4 2021 and held it in 1 quarter. The position peaked at $809K in Q4 2021. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

CIM LLC reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
CIM LLC sold 2,139 West Pharmaceutical shares in Q1 2022, an estimated $809K.
CIM LLC first reported a position in West Pharmaceutical in Q4 2021 and held it in 1 quarter.
CIM LLC's West Pharmaceutical position peaked at $809K in Q4 2021.
717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on CIM LLC's 13F filing for Q1 2022, filed 12 Apr 2022.